ZA991785B - Therapeutic treatment for cytomegalovirus infection. - Google Patents

Therapeutic treatment for cytomegalovirus infection.

Info

Publication number
ZA991785B
ZA991785B ZA9901785A ZA991785A ZA991785B ZA 991785 B ZA991785 B ZA 991785B ZA 9901785 A ZA9901785 A ZA 9901785A ZA 991785 A ZA991785 A ZA 991785A ZA 991785 B ZA991785 B ZA 991785B
Authority
ZA
South Africa
Prior art keywords
therapeutic treatment
cytomegalovirus infection
cytomegalovirus
infection
therapeutic
Prior art date
Application number
ZA9901785A
Other languages
English (en)
Inventor
Douglas Kirk Ways
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA991785B publication Critical patent/ZA991785B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA9901785A 1998-03-05 1999-03-05 Therapeutic treatment for cytomegalovirus infection. ZA991785B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7685798P 1998-03-05 1998-03-05

Publications (1)

Publication Number Publication Date
ZA991785B true ZA991785B (en) 1999-09-06

Family

ID=22134607

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9901785A ZA991785B (en) 1998-03-05 1999-03-05 Therapeutic treatment for cytomegalovirus infection.

Country Status (7)

Country Link
US (1) US6291446B1 (xx)
EP (1) EP0940141A3 (xx)
JP (1) JP2002505283A (xx)
AU (1) AU3071799A (xx)
CA (1) CA2323158A1 (xx)
WO (1) WO1999044605A1 (xx)
ZA (1) ZA991785B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1201765A3 (en) * 2000-10-16 2003-08-27 Axxima Pharmaceuticals Aktiengesellschaft Cellular kinases involved in cytomegalovirus infection and their inhibition
US7114084B2 (en) * 2002-03-06 2006-09-26 Micron Technology, Inc. Data controlled programmable power supply
DK3156069T3 (da) 2008-06-20 2020-09-21 Univ Duke Sammensætninger, fremgangsmåder, og kits til fremkaldelse af et immunrespons
EP2177510A1 (en) 2008-10-17 2010-04-21 Universität des Saarlandes Allosteric protein kinase modulators
US11382919B2 (en) 2017-11-30 2022-07-12 Albert Einstein College Of Medicine Prevention and treatment of viral infections

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ227850A (en) 1988-02-10 1991-11-26 Hoffmann La Roche Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders
ZA908935B (en) 1989-11-13 1991-08-28 Merrell Dow Pharma Prevention of glycoprotein enveloped virus infectivity by pyridinyloxazole-2-ones
DE4243321A1 (de) 1992-12-21 1994-06-23 Goedecke Ag Aminosäurederivate von Heterocyclen als PKC-Inhibitoren
UA44690C2 (uk) 1993-12-07 2002-03-15 Елі Ліллі Енд Компані Макроциклічна сполука іміду біс-індол-малеїнової кислоти, спосіб її одержання та фармацевтична композиція, макроциклічні сполуки іміду біс-індол-малеїнової кислоти та біс-індол-малеїнового ангідриду, спосіб одержання (варіанти)
US5624949A (en) 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
JPH07238044A (ja) 1993-12-07 1995-09-12 Eli Lilly & Co ビスインドリルマレイミドの改良合成法
US5545636A (en) 1993-12-23 1996-08-13 Eli Lilly And Company Protein kinase C inhibitors
US5491242A (en) 1994-06-22 1996-02-13 Eli Lilly And Company Protein kinase C inhibitors
US5481003A (en) 1994-06-22 1996-01-02 Eli Lilly And Company Protein kinase C inhibitors
US5559228A (en) 1995-03-30 1996-09-24 Eli Lilly And Company Synthesis of bisindolylmaleimides
EA000967B1 (ru) 1995-11-20 2000-08-28 Эли Лилли Энд Компани Ингибитор протеинкиназы c
US6107327A (en) * 1996-08-30 2000-08-22 Eli Lilly And Company Therapeutic treatment for HIV infection

Also Published As

Publication number Publication date
US6291446B1 (en) 2001-09-18
CA2323158A1 (en) 1999-09-10
EP0940141A3 (en) 1999-09-29
EP0940141A2 (en) 1999-09-08
WO1999044605A1 (en) 1999-09-10
AU3071799A (en) 1999-09-20
JP2002505283A (ja) 2002-02-19

Similar Documents

Publication Publication Date Title
AU7842500A (en) System for orthopedic treatment
HK1075881A1 (en) Fluid treatment system
ZA978450B (en) Medical treatment
MX264033B (es) Tratamieno de enzimas para infeccion.
GB9800942D0 (en) Well treatment
ZA9811715B (en) Aqueous insecticidal pour-on treatment.
ZA973209B (en) Therapeutic compounds.
GB9925136D0 (en) Novel treatment
ZA200105690B (en) Novel treatment.
ZA991785B (en) Therapeutic treatment for cytomegalovirus infection.
ZA991783B (en) Therapeutic treatment for autoimmune diseases.
ZA991786B (en) Therapeutic treatment for asthma.
HK1021946A1 (en) Electromagnetic therapeutic treatment device.
GB0020261D0 (en) Therapeutic treatment
ZA9610761B (en) Medical treatment.
GB9704174D0 (en) Agent for medical treatment
AU3698199A (en) Radioimmuno-pharmacon for treating the hiv-1 infection
GB9818524D0 (en) Inorgasmia treatment
GB9815497D0 (en) Treatment
GB9828550D0 (en) Treatment
GB9923343D0 (en) Treatment system
GB9710544D0 (en) Medical treatment
GB9903558D0 (en) Medical treatment
GB9901505D0 (en) Therapeutic treatment
GB9918785D0 (en) Therapeutic treatment